Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins.

Hefter, Harald; Hartmann, Christian J; Kahlen, Ulrike; Samadzadeh, Sara; Rosenthal, Dietmar; Moll, Marek

Hefter, Harald; Hartmann, Christian J; Kahlen, Ulrike; Samadzadeh, Sara; Rosenthal, Dietmar; Moll, Marek.

Afiliação

Hefter H; Department of Neurology, University of Düsseldorf, Düsseldorf, Germany.
Hartmann CJ; Department of Neurology, University of Düsseldorf, Düsseldorf, Germany.
Kahlen U; Department of Neurology, University of Düsseldorf, Düsseldorf, Germany.
Samadzadeh S; Department of Neurology, University of Düsseldorf, Düsseldorf, Germany.
Rosenthal D; Department of Neurology, University of Düsseldorf, Düsseldorf, Germany.
Moll M; Department of Neurology, University of Düsseldorf, Düsseldorf, Germany.

Front Neurol ; 12: 636590, 2021.

Article em En | MEDLINE | ID: mdl-33633680

Palavras-chave

cervical dystonia; complexing proteins; incobotulinumtoxinA; neutralizing antibodies; partial secondary therapy failure

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Front Neurol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google